Kalsiyum Kanal Blokörleri Zehirlenmeleri
Synopsis
Kalsiyum kanal blokerleri (KKB), hipertansiyon, anjina pektoris, kardiyak aritmiler ve diğer kardiyovasküler bozuklukların tedavisinde yaygın olarak kullanılan, L-tipi kalsiyum kanallarını bloke eden önemli bir ilaç sınıfıdır. Dihidropiridin grubu ilaçlar (nifedipin, amlodipin) esas olarak güçlü periferik vazodilatasyona ve refleks taşikardiye neden olurken, dihidropiridin olmayanlar (verapamil, diltiazem) miyokardiyal iletim ile kontraktiliteyi baskılayarak belirgin bradikardi ve hipotansiyona yol açar; fakat yüksek doz aşımında bu grup seçiciliği kaybolabilir. KKB zehirlenmelerinde klinik tablo derin hipotansiyon, bradikardi, EKG'de PR aralığı uzaması, bradiaritmiler ve kalsiyum aracılı insülin salınımının inhibisyonuna bağlı hiperglisemi ile seyredebilir. KKB'ler yüksek oranda proteine bağlandığı ve geniş bir dağılım hacmine sahip olduğu için hemodiyaliz gibi ekstrakorporeal uzaklaştırma yöntemleri tedavide etkisiz kalmaktadır. İlk aşama yönetimde hava yolu stabilizasyonu, IV izotonik kristaloid sıvı resüsitasyonu, atropin ve alım zamanına uygun gastrointestinal dekontaminasyon (aktif kömür, orogastrik lavaj veya tüm bağırsak irrigasyonu) temel adımlardır. Şiddetli ve dirençli vakalarda intravenöz kalsiyum tuzları, glukagon, vazopressörler (özellikle norepinefrin), yüksek doz insülin-glukoz tedavisi ve lipid emülsiyon tedavisi eş zamanlı olarak uygulanmalıdır. Standart tedavilere yanıt vermeyen vakalarda ise son çare olarak ekstrakorporeal membran oksijenasyonu (ECMO) düşünülebilir. Asemptomatik hastalar ilacın salınım yapısına göre 6 ila 24 saat boyunca kardiyak izlemle takip edilmeli, kasıtlı aşırı doz şüphesinde psikiyatrik değerlendirme sağlanmalıdır.
Calcium channel blockers (CCBs) are an important class of medications widely used in the treatment of hypertension, angina pectoris, cardiac arrhythmias, and other cardiovascular disorders by blocking L-type calcium channels. Dihydropyridine class drugs (such as nifedipine and amlodipine) primarily cause potent peripheral vasodilation and reflex tachycardia, whereas non-dihydropyridines (verapamil, diltiazem) suppress myocardial conduction and contractility, leading to marked bradycardia and hypotension; however, this class selectivity may be lost in high-dose overdoses. The clinical presentation in CCB toxicity may include severe hypotension, bradycardia, PR interval prolongation and bradyarrhythmias on ECG, and hyperglycemia resulting from the inhibition of calcium-mediated insulin release. Because CCBs are highly protein-bound and have a large volume of distribution, extracorporeal removal methods such as hemodialysis remain ineffective. Initial management steps include airway stabilization, IV isotonic crystalloid fluid resuscitation, atropine, and gastrointestinal decontamination (activated charcoal, orogastric lavage, or whole bowel irrigation) appropriate to the time of ingestion. In severe and refractory cases, intravenous calcium salts, glucagon, vasopressors (especially norepinephrine), high-dose insulin-glucose therapy, and lipid emulsion therapy should be administered concurrently. In cases non-responsive to standard therapies, extracorporeal membrane oxygenation (ECMO) may be considered as a last resort. Asymptomatic patients should be monitored with cardiac tracking for 6 to 24 hours depending on the drug formulation, and psychiatric evaluation must be ensured in cases of suspected intentional overdose.
References
Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers: an update. Am J Med 2004; 116:35.
Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21:353.
Katz AM. Cardiac ion channels. N Engl J Med 1993; 328:1244.
Hofer CA, Smith JK, Tenholder MF. Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options. Am J Med 1993; 95:431.
McAllister RG Jr, Hamann SR, Blouin RA. Pharmacokinetics of calcium-entry blockers. Am J Cardiol 1985; 55:30B.
Lindeman E, Ålebring J, Johansson A, et al. The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study. Clin Toxicol (Phila) 2020; 58:1042.
Sporer KA, Khayam-Bashi H. Acetaminophen and salicylate serum levels in patients with suicidal ingestion or altered mental status. Am J Emerg Med 1996; 14:443.
Spurlock BW, Virani NA, Henry CA. Verapamil overdose. West J Med 1991; 154:208.
Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med 2007; 35:2071.
St-Onge M, Dubé PA, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila) 2014; 52:926.
Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci 1995; 310:258.
Thompson AM, Robins JB, Prescott LF. Changes in cardiorespiratory function during gastric lavage for drug overdose. Hum Toxicol 1987; 6:215.
Thanacoody R, Caravati EM, Troutman B, et al. Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol (Phila) 2015; 53:5.
Tenenbein M. Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:753.
Tenenbein M, Cohen S, Sitar DS. Whole bowel irrigation as a decontamination procedure after acute drug overdose. Arch Intern Med 1987; 147:905.
Proano L, Chiang WK, Wang RY. Calcium channel blocker overdose. Am J Emerg Med 1995; 13:444.
Kerns W 2nd, Kline J, Ford MD. Beta-blocker and calcium channel blocker toxicity. Emerg Med Clin North Am 1994; 12:365.
Isbister GK. Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium. Emerg Med J 2002; 19:355.
Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest 2001; 119:1280.
DeRoos F. Calcium channel blockers. In: Goldfrank's Toxicologic Emergencies, 8th, McGraw-Hill, New York 2006.
Sim MT, Stevenson FT. A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose. J Med Toxicol 2008; 4:25.
Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol 2003; 41:595.
Mahr NC, Valdes A, Lamas G. Use of glucagon for acute intravenous diltiazem toxicity. Am J Cardiol 1997; 79:1570.
Walter FG, Frye G, Mullen JT, et al. Amelioration of nifedipine poisoning associated with glucagon therapy. Ann Emerg Med 1993; 22:1234.
Doyon S, Roberts JR. The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22:1229.
Levine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med 2013; 62:252.
Kline JA, Tomaszewski CA, Schroeder JD, Raymond RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther 1993; 267:744.
Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344:1721.
Greene SL, Gawarammana I, Wood DM, et al. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med 2007; 33:2019.
Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review. Am J Crit Care 2007; 16:498.
Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251.
Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997; 145:357.
Bechtel LK, Haverstick DM, Holstege CP. Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway. Acad Emerg Med 2008; 15:368.
Jamaty C, Bailey B, Larocque A, et al. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol (Phila) 2010; 48:1.
Levine M, Hoffman RS, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol (Phila) 2016; 54:194.
Gosselin S, Hoegberg LC, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning(). Clin Toxicol (Phila) 2016; 54:899.
Young AC, Velez LI, Kleinschmidt KC. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose. Resuscitation 2009; 80:591.
Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008; 51:412.
Doepker B, Healy W, Cortez E, Adkins EJ. High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and Beta-blocker overdose: a case series. J Emerg Med 2014; 46:486.
Bologa C, Lionte C, Coman A, Sorodoc L. Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose--case report. Am J Emerg Med 2013; 31:1154.e3.
Gueret G, Pennec JP, Arvieux CC. Hemodynamic effects of intralipid after verapamil intoxication may be due to a direct effect of fatty acids on myocardial calcium channels. Acad Emerg Med 2007; 14:761.
Durward A, Guerguerian AM, Lefebvre M, Shemie SD. Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med 2003; 4:372.
Babatasi G, Massetti M, Verrier V, et al. [Severe intoxication with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance]. Arch Mal Coeur Vaiss 2001; 94:1386.
Vignesh C, Kumar M, Venkataraman R, et al. Extracorporeal Membrane Oxygenation in Drug Overdose: A Clinical Case Series. Indian J Crit Care Med 2018; 22:111.
2021 UpToDate®, Calcium channel blocker poisoning.